Ridgepost Capital Reports Second Quarter 2026 Financial Results
Go back to Ridgepost Capital Reports Second Quarter 2026 Financial Results| Radient Pharmaceuticals (NYSE: RPC) | Delayed: 7.62 +0.12 (1.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.50 | 52 Week High | $1.69 | |||
| Open | $7.60 | 52 Week Low | $0.14 | |||
| Day High | $7.69 | P/E | N/A | |||
| Day Low | $7.50 | EPS | $-3.02 | |||
| Volume | 520,909 | |||||
| Radient Pharmaceuticals (NYSE: RPC) | Delayed: 7.62 +0.12 (1.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.50 | 52 Week High | $1.69 | |||
| Open | $7.60 | 52 Week Low | $0.14 | |||
| Day High | $7.69 | P/E | N/A | |||
| Day Low | $7.50 | EPS | $-3.02 | |||
| Volume | 520,909 | |||||

